Early Cash Oxycodone Fill With Multiple PMP Red Flags
On a Tuesday evening, a 34-year-old woman presents a paper prescription for oxycodone 30 mg, #120, one tablet every 8 hours as needed, written three days earlier by a pain-management physician 80 miles away. She asks to pay cash and says she is traveling tomorrow. The pharmacy last filled the same strength and quantity for her 18 days ago; the prescription says it is a new prescription, not a refill. A PMP query shows fills 18 days ago at another pharmacy, alprazolam 2 mg from a different prescriber 12 days ago, and a hydrocodone/acetaminophen fill 30 days ago from a third prescriber. The patient says the first oxycodone pharmacy was 'out of stock.' The prescriber's office is closed and the on-call service says the physician will call back, but no call comes before closing.
1. What must the pharmacist do before deciding whether to fill this prescription?
Read the worked answer
The pharmacist must resolve the red flags before dispensing. The PMP query is central: it shows recent opioid use from another pharmacy, a benzodiazepine from a different prescriber, and another opioid from a third prescriber. The cash payment, distance from the prescriber, early refill request, and multiple prescribers increase concern under the pharmacist's corresponding responsibility to ensure a controlled substance is issued for a legitimate medical purpose.
The pharmacist should verify the prescription's authenticity, confirm the patient's identity, review the full PMP profile for overlapping therapy, and contact the prescriber. The pharmacist should ask about the diagnosis, the reason for the new oxycodone prescription so soon after the prior fill, and the concurrent alprazolam. If the prescriber cannot be reached or the explanation does not resolve the inconsistencies, the pharmacist should not fill.
2. Can the pharmacist fill the oxycodone because the patient says the other pharmacy was out of stock?
Read the worked answer
No. A patient's explanation is a starting point, not verification. The pharmacist should check whether the prior oxycodone fill was actually dispensed and whether the new prescription is a legitimate replacement or an early duplicate. The PMP and the pharmacy records should be reconciled. If the prior fill was dispensed 18 days ago, a new #120 oxycodone prescription creates a significant early-supply issue.
The pharmacist may fill only after the prescriber confirms the clinical rationale and the pharmacist resolves the overlapping opioid and benzodiazepine risks. If the prescriber does not call back, the default is to decline rather than dispense on an unverified story. The pharmacist should return the prescription to the patient with a clear explanation and document the decision.
3. What documentation and follow-up are appropriate if the pharmacist declines to fill?
Read the worked answer
Document the prescription details, the PMP findings, the contact attempts with the prescriber and on-call service, the patient statements, the specific red flags, and the reason for refusal. Note that the prescription was not dispensed and whether it was returned to the patient. Avoid labeling the patient as a drug seeker; record objective facts and clinical reasoning.
If the pharmacist suspects forgery or diversion, follow pharmacy policy and Louisiana reporting requirements, including notifying the Board or law enforcement when appropriate. The pharmacist should also consider counseling on safety, naloxone availability, and the risks of combining an opioid with a benzodiazepine. The key is that the refusal is documented as a professional judgment, not an arbitrary denial.